244 related articles for article (PubMed ID: 25047370)
1. Intracellular lipid accumulation and shift during diabetes progression.
Wolf P; Winhofer Y; Anderwald CH; Krššák M; Krebs M
Wien Med Wochenschr; 2014 Aug; 164(15-16):320-9. PubMed ID: 25047370
[TBL] [Abstract][Full Text] [Related]
2. [Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy].
Stratmann B; Worms J; Tschoepe D
Dtsch Med Wochenschr; 2014 Oct; 139(40):2006-9. PubMed ID: 25254396
[No Abstract] [Full Text] [Related]
3. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
Saponaro C; Gaggini M; Gastaldelli A
Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
[TBL] [Abstract][Full Text] [Related]
4. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).
Tanase DM; Gosav EM; Costea CF; Ciocoiu M; Lacatusu CM; Maranduca MA; Ouatu A; Floria M
J Diabetes Res; 2020; 2020():3920196. PubMed ID: 32832560
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
Firneisz G
World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080
[TBL] [Abstract][Full Text] [Related]
6. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
[TBL] [Abstract][Full Text] [Related]
7. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations.
Arrese M; Barrera F; Triantafilo N; Arab JP
Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):849-866. PubMed ID: 31353974
[No Abstract] [Full Text] [Related]
8. Changes in Titin and Collagen Modulate Effects of Aerobic and Resistance Exercise on Diabetic Cardiac Function.
Li S; Liang M; Gao D; Su Q; Laher I
J Cardiovasc Transl Res; 2019 Oct; 12(5):404-414. PubMed ID: 30820865
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
[TBL] [Abstract][Full Text] [Related]
10. Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Jia G; Di F; Wang Q; Shao J; Gao L; Wang L; Li Q; Li N
PLoS One; 2015; 10(11):e0142808. PubMed ID: 26566287
[TBL] [Abstract][Full Text] [Related]
11. Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus.
Tsai LW; Lu YH; Dubey R; Chiou JF
J Diabetes Res; 2021; 2021():7692447. PubMed ID: 34805412
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes.
Vadini F; Simeone PG; Desideri G; Liani R; Tripaldi R; Ciotti S; Tartaro A; Guagnano MT; Di Castelnuovo A; Cipollone F; Consoli A; Santilli F
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2685-2692. PubMed ID: 34226120
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment.
Leite NC; Villela-Nogueira CA; Cardoso CR; Salles GF
World J Gastroenterol; 2014 Jul; 20(26):8377-92. PubMed ID: 25024596
[TBL] [Abstract][Full Text] [Related]
14. Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease.
Wu W; Sun Z; Li Q; Wang M; Miao J; Zheng Z; Sun L; Huang J; Wang Y; Zhang H; Hu C
J Diabetes Complications; 2012; 26(2):83-8. PubMed ID: 22475635
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Steatosis as a Marker of Metabolic Dysfunction.
Fabbrini E; Magkos F
Nutrients; 2015 Jun; 7(6):4995-5019. PubMed ID: 26102213
[TBL] [Abstract][Full Text] [Related]
16. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
Kawashima Y; Chen J; Sun H; Lann D; Hajjar RJ; Yakar S; Leroith D
Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
[TBL] [Abstract][Full Text] [Related]
18. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.
Roberts TJ; Burns AT; MacIsaac RJ; MacIsaac AI; Prior DL; La Gerche A
Cardiovasc Diabetol; 2018 Mar; 17(1):44. PubMed ID: 29571290
[TBL] [Abstract][Full Text] [Related]
19. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.
Tanaka H; Tatsumi K; Matsuzoe H; Matsumoto K; Hirata KI
Cardiovasc Diabetol; 2020 Jun; 19(1):84. PubMed ID: 32534593
[TBL] [Abstract][Full Text] [Related]
20. Diabetic cardiomyopathy: ongoing controversies in 2012.
Seferović PM; Milinković I; Ristić AD; Seferović Mitrović JP; Lalić K; Jotić A; Kanjuh V; Lalić N; Maisch B
Herz; 2012 Dec; 37(8):880-6. PubMed ID: 23223771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
